Verastem, Inc. (VSTM) - Earnings & Price History

VSTM: Verastem, Inc. - 3.58, $139.46M, -0.24 (-6.28%)

Sector: Healthcare - Industry: Biotechnology

Verastem, Inc., a biopharmaceutical company, focuses on discovering and developing drugs targeting cancer stem cells (CSCs). Its programs target the focal adhesion kinase (FAK) and the PI3K/mTOR signaling pathways. The companys product candidate FAK inhibitor, VS-6063, is in Phase 1 study in combination with PD-1 inhibitor pembrolizumab and gemcitabine for pancreatic cancer; a Phase Ib clinical trial in combination with paclitaxel for patients with ovarian cancer; a Phase II study in patients with non-small cell lung cancer; a Phase II trial preceding surgery in mesothelioma; and a Phase 1/1b clinical trail in combination with avelumab in patients with ovarian cancer, as well as a combination trial of VS-6063 and VS-5584 in patients with relapsed mesothelioma. It is also developing FAK inhibitor, VS-4718 that is in Phase 1, single-agent, dose escalation trial in patients with advanced ca

Past VSTM reports
Earning DateTimeTitleEPS-e EPS-a ClosePrev CloseOpen Day LowDay High Gap % CFO %Change % Volume
2017-03-01-0.261.131.151.151.121.17-1.74%-1.74%128.20K
2016-11-07-0.241.131.131.171.081.173.54%▲-3.42%181.94K
2016-08-08-0.291.351.321.331.321.360.76%1.50%2.27%226.16K
2016-05-09-0.31.451.41.451.41.493.57%3.57%159.51K
2016-03-03-0.361.371.431.471.351.472.80%-6.80%-4.20%763.99K
2015-11-09-0.442.112.132.152.072.20.94%▲-1.86%-0.94%478.23K
2015-08-10-0.457.696.976.936.827.81-0.57%10.97%10.33%586.67K
2015-08-07-0.45
2015-08-06-0.456.927.127.016.797.15-1.54%-1.28%-2.81%292.50K
2015-08-05-0.457.0357.127.1577.170.42%-1.61%-1.19%15.43K
2014-11-11Verastem Inc-0.51-0.529.379.29.159.149.41-0.54%▲2.40%1.85%271.60K
2014-08-12Verastem Inc-0.52-0.518.98.548.588.58.990.47%3.73%4.22%139.50K
2014-05-08Verastem Inc-0.45-0.517.457.147.147.147.894.34%4.34%254.80K
2014-03-06BMOVerastem Inc-0.44-0.4514.2314.2714.2213.7714.44-0.35%0.07%-0.28%455.10K
2013-11-12Verastem Inc-0.44-0.4710.110.1610.089.8511-0.79%▲0.20%-0.59%141.40K
2013-08-12Verastem Inc-0.44-0.4914.6214.931514.5915.20.47%-2.53%-2.08%127.40K
2013-05-13Verastem Inc-0.39-0.449.719.739.389.39.86-3.60%3.52%-0.21%27.50K
2013-03-27BMO-0.429.599.589.529.469.59-0.63%0.74%0.10%4.86K
2012-11-13BMO-0.366.756.656.536.536.85-1.80%▲3.37%1.50%5.29K
2012-08-13BMOQ2 2012 Verastem Inc-0.348.028.928.997.79.30.78%-10.79%-10.09%12.90K
2012-06-13Verastem Inc-0.28-0.4710.449.389.329.3210.44-0.64%12.02%11.30%3.20K
2012-03-14BMOVerastem Inc-0.241111.210.9710.9111.4-2.05%0.27%-1.79%16.20K

Login | Register
Tuesday Dec 18, 2018   EST
Enter a Ticker:

Economic Calendar

AAII Sentiment Survey

BULL^ neut ^ BEAR

Chart

index chart
index color
SPY257.6450.500.19%41,867,194

Upgrades/Downgrades